Prandi, Davide
 Distribuzione geografica
Continente #
NA - Nord America 5.495
AS - Asia 1.567
EU - Europa 1.259
SA - Sud America 225
Continente sconosciuto - Info sul continente non disponibili 142
AF - Africa 30
OC - Oceania 23
Totale 8.741
Nazione #
US - Stati Uniti d'America 5.401
SG - Singapore 613
VN - Vietnam 322
CN - Cina 305
IT - Italia 301
RU - Federazione Russa 209
BR - Brasile 178
FI - Finlandia 111
GB - Regno Unito 103
DE - Germania 102
SE - Svezia 82
UA - Ucraina 82
HK - Hong Kong 73
FR - Francia 70
CA - Canada 60
KR - Corea 50
LV - Lettonia 50
IN - India 42
ES - Italia 34
BG - Bulgaria 27
ID - Indonesia 24
JP - Giappone 23
BD - Bangladesh 22
AU - Australia 20
NL - Olanda 20
JO - Giordania 19
AR - Argentina 15
LU - Lussemburgo 15
MX - Messico 15
PL - Polonia 15
AT - Austria 12
CO - Colombia 11
IQ - Iraq 11
ZA - Sudafrica 11
TR - Turchia 10
PK - Pakistan 9
EC - Ecuador 8
IE - Irlanda 6
VE - Venezuela 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
IL - Israele 5
LT - Lituania 5
MY - Malesia 5
UZ - Uzbekistan 5
TW - Taiwan 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
HN - Honduras 3
JM - Giamaica 3
KE - Kenya 3
MA - Marocco 3
NZ - Nuova Zelanda 3
PE - Perù 3
XK - ???statistics.table.value.countryCode.XK??? 3
BH - Bahrain 2
BN - Brunei Darussalam 2
CH - Svizzera 2
CL - Cile 2
EE - Estonia 2
ET - Etiopia 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
PH - Filippine 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AW - Aruba 1
AZ - Azerbaigian 1
BB - Barbados 1
CD - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EU - Europa 1
HR - Croazia 1
HT - Haiti 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TG - Togo 1
TN - Tunisia 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
Totale 8.603
Città #
Ashburn 588
Fairfield 550
Singapore 369
Chandler 359
San Jose 312
Seattle 265
Woodbridge 253
Houston 211
Cambridge 210
Wilmington 203
Jacksonville 188
Dallas 155
Santa Clara 134
Columbus 126
Ann Arbor 123
San Mateo 114
Ho Chi Minh City 99
Los Angeles 88
Moscow 86
Trento 84
Council Bluffs 77
New York 77
Hanoi 73
Princeton 73
Helsinki 69
Hong Kong 65
San Francisco 56
Beijing 53
The Dalles 52
Riga 50
San Diego 50
Seoul 46
Lauterbourg 42
Boardman 39
Dearborn 36
Phoenix 34
Bremen 29
Munich 27
Sofia 27
Chicago 24
Da Nang 24
Como 22
London 22
Orem 22
Lawrence 21
Buffalo 20
Jakarta 19
Boston 18
Melbourne 18
Milan 18
Redondo Beach 18
São Paulo 18
Barcelona 17
Dublin 16
Frankfurt am Main 16
Montreal 16
Vancouver 16
Atlanta 15
Hesperange 15
Salt Lake City 15
San Paolo di Civitate 15
Haiphong 14
Tokyo 14
Brooklyn 13
Hefei 13
Dong Ket 12
Staranzano 12
Guangzhou 11
Manchester 11
Changsha 10
Chennai 10
Shanghai 10
Johannesburg 9
Toronto 9
Warsaw 9
Poplar 8
Riva Del Garda 8
Rome 8
Tampa 8
Denver 7
Mooresville 7
New Delhi 7
Norwalk 7
Nuremberg 7
Palo Alto 7
Rio de Janeiro 7
Turku 7
Washington 7
Kilburn 6
Mumbai 6
Saint Paul 6
Salem 6
Utrecht 6
Vienna 6
Amman 5
Bogotá 5
Brasília 5
Curitiba 5
Elk Grove Village 5
Mexico City 5
Totale 6.215
Nome #
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit 383
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer 381
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer 356
A highly specific SpCas9 variant is identified by in vivo screening in yeast 353
Genomic correlates of clinical outcome in advanced prostate cancer 299
Personalized in vitro and in vivo cancer models to guide precision medicine 256
ASEQ: Fast allele-specific studies from next-generation sequencing data 253
Patient derived organoids to model rare prostate cancer phenotypes 249
Communicating by compatibility 235
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers 233
Clonal evolution of chemotherapy-resistant urothelial carcinoma 210
Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer 208
Formal Analysis of BPMN Via a Translation into COWS 193
Predicting the effects of parameters changes in stochastic modelsthrough parallel synthetic experiments and multivariate analysis 189
TPES: Tumor Purity Estimation from SNVs 188
A Formal Approach to Molecular Docking 188
The Molecular Taxonomy of Primary Prostate Cancer 187
Beta-binders for Biological Quantitative Experiments 182
Taming the complexity of biological pathways through parallel computing 180
Beta-binders for biological quantitative experiments 178
Shape Spaces in Formal Interactions 170
Shape spaces in formal interactions 164
Process Calculi Abstractions for Biology 158
Process Calculi Abstractions for Biology 157
Developing An Hierarchical Simulator for Beta-binders 157
Exploiting non-Markovian Bio-Processes 157
Developing An Hierarchical Simulator for Beta-binders 153
Communicating by Compatibility 152
Punctuated evolution of prostate cancer genomes. 148
Formal executable descriptions of biological systems 145
Next-generation rapid autopsies enable tumor evolution tracking and generation of preclinical models 144
GPU computing for systems biology 143
Effective Index: A Formal Measure of Drug Effects 140
Tumor clone dynamics in lethal prostate cancer 139
Stability Analysis of Biological Network Topologies during Stochastic Simulation 137
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity 135
Unraveling the clonal hierarchy of somatic genomic aberrations 132
CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer 127
Proteomic and genomic signatures of repeat instability in cancer and adjacent normal tissues 126
SPOP mutation leads to genomic instability in prostate cancer 121
Purpose Control: Did You Process the Data for the Intended Purpose? 120
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer 117
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response 107
Ploidy- and Purity-Adjusted Allele-Specific DNA Analysis Using CLONETv2 107
Stochastic COWS 102
Stochastic COWS 101
Effective Index: A Formal Measure of Drug Effects 84
Process Calculi in a Biological Context 68
Process Calculi Abstractions for Biology 66
Simulation of non-Markovian Processes in BlenX 63
Totale 8.741
Categoria #
all - tutte 33.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.094
Totale 34.791


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022470 0 0 0 20 6 33 12 148 26 54 60 111
2022/2023772 133 100 12 117 80 104 9 58 91 11 37 20
2023/2024289 20 26 18 10 39 74 22 30 1 13 7 29
2024/20251.117 10 8 56 232 60 125 34 49 133 207 92 111
2025/20262.875 210 85 341 354 273 175 580 75 255 255 146 126
2026/2027554 59 149 264 82 0 0 0 0 0 0 0 0
Totale 8.741